학술논문
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Document Type
Article
Author
Source
In: Nature Communications . (Nature Communications, December 2022, 13(1))
Subject
Language
English
ISSN
20411723